Showing results (2301-2310 of 2,790) with videos related to
Sort By:
Pageof 279
Journal of Hepatology|April 28, 2016
Novel patient-derived xenograft and cell line models for therapeutic testing of pediatric liver cancerBeatrice Bissig-Choisat, Claudia Kettlun-Leyton, Xavier D Legras, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 28, 2015
The Emergence of Zoonotic Onchocerca lupi Infection in the United States--A Case-SeriesPaul T Cantey, Jessica Weeks, Morven Edwards, et al.Journal of the National Cancer Institute|May 1, 2013
Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACENasim Mavaddat, Susan Peock, Debra Frost, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 23, 2018
Risks of breast or ovarian cancer in BRCA1 or BRCA2 predictive test negatives: findings from the EMBRACE studyFabio Girardi, Daniel R Barnes, Daniel Barrowdale, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 14, 2020
Timing of Antiretroviral Therapy Initiation and Risk of Cancer Among Persons Living With Human Immunodeficiency VirusMichael J Silverberg, Wendy Leyden, Raúl U Hernández-Ramírez, et al.AIDS Research and Therapy|December 17, 2010
CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation?Keri N Althoff, Kelly A Gebo, Stephen J Gange, et al.Vaccine|December 5, 2006
Implementation of good clinical practice guidelines in vaccine trials in developing countriesCamilo J Acosta, Claudia M Galindo, R Leon Ochiai, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2013
Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancerElena Castro, Chee Goh, David Olmos, et al.The Journal of Clinical Investigation|November 13, 2012
HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolatesR Brad Jones, Keith E Garrison, Shariq Mujib, et al.Journal of Medical Genetics|October 6, 2010
Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancersK A Schrader, S Masciari, N Boyd, et al.Pageof 279